Room for improvement in the management of scleroderma associated PAH

Sponsored by Actelion Pharmaceuticals

It’s a rare type of hypertension associated with one of the most severe organ complications affecting around 15-501 in one million people among the general population. But among patients with systemic scleroderma (SSc), pulmonary arterial hypertension (PAH) remains the major cause of death, with the debilitating condition affecting as many as 1 in 102 patients. ...

Already a member?

Login to keep reading.

© 2021 the limbic